A complete application in a minute
Tailored resume and cover letter, ready to send.
Johnson & Johnson is seeking a Medical Science Liaison (MSL) in Madrid to maximize product value through high-quality scientific communication with leading specialists. The role focuses on peer-to-peer discussions, therapeutic area expertise, and strategic alignment with Medical Affairs plans.
The MSL will discuss treatments, patient trends, and studies, build networks with key specialists, and represent the company in professional associations to advance scientific exchange.
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com .
As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.
Medical Affairs Group
Medical Science Liaison
Scientific/Technology
Madrid, Spain
To maximize company product value through high scientific quality communication with Leading Specialists on a peer-to-peer basis. Accordingly, to strategic lines of Medical Affairs Plan, the MSL is jointly responsible for achieving short-term and long-term company goals at local level.
To be a therapeutic area scientific expert, responsible for discussing our products, patients' treatment trends and studies in the therapeutic areas in which we are involved, on a peer-to-peer basis with a defined audience of Leading Specialists (Physicians, Pharmacists, Hospital Managers, Board Members of Scientific Societies, and other stakeholders) and to be considered an internal and external trusted scientific counterpart.
Proactive Scientific Communication to Leading Specialists must be consistent with the last approved Summary of Product Characteristics regarding the safe and effective use of approved products in approved indications. Content of Scientific Communication should be highly scientific, accurate, fair and objective, based on an up-to-date evaluation of all relevant evidence and reflect that evidence clearly, using neither marketing claims nor brand name, for individual or groups of physicians (group calls)
In some very specific circumstances, the MSL can interact proactively with non-Leading Specialists. The program should be clearly defined in the MSL Country Activity Plan, providing the rational, the objective, content, timelines and selection criteria of the HCPs to be involved
Description of R&D programs and discussing regulatory developments with no promotional intent are also part of Scientific Communication.
Reactive Communication of medical scientific data can be provided upon request to any Health Care Professional, within the approved label or off-label. The request should come either directly from the HCP or via the Medical Information department. MSLs are required to document all off-label information requests they receive from Leading Specialists and other HCPs that they may interact with.
MSLs can present highly scientific, accurate, fair and objective data to Payors (Hospital Formulary Committees, Health Insurers, Health Technology Assessment Committees, etc